Public platform demo

From viral antigen maps to manufacturable mRNA-LNP vaccine candidates.

Onco-vira is an AI-native mRNA vaccine design platform mapping shared viral tumour antigens to Asian HLA populations.

Open interactive workspace Explore modules
OV-101 lead program HBV-HCC workflow Asian HLA fit Closed-loop learning
Company AI-native mRNA vaccine platform for Asian viral oncology.
Platform Shared viral antigens → Asian HLA fit → construct candidates.
First product OV-101 for adjuvant HBV-related hepatocellular carcinoma.
Platform flow

A guided system for candidate selection.

The demo is designed as a public product experience: select a program, tune analysis priorities, run the workflow, and view the candidate recommendation.

Interactive workspace

HBV-HCC Antigen-to-Construct Workflow

Use the controls to change the program view and scoring emphasis. The workspace updates the ranking, recommendation, readiness view, and activity log.

Lead / Pre-IND

OV-101 · HBV-HCC adjuvant

Off-the-shelf HBV-shared-antigen mRNA vaccine candidate for adjuvant treatment of HBV-related HCC.

Priority 95
Antigen Discovery Engine

Shared HBV antigen shortlist

HLA Optimiser

Population coverage view

Asian HLA weighted
Construct Studio

Lead and backup candidates

OV-101A lead
LNP Intelligence

Translation readiness map

Product pathway view
System activity

Demo workflow log

Modules

Six connected platform modules.

Click a module to update the detail card. Each module turns part of the scientific workflow into a clearer product decision.

Data Engine
Pipeline map

One lead program, multiple platform extensions.

The public demo shows how the same workflow can be reused across HBV, EBV, and HPV-associated cancers.

Clinical Learning Loop

Every program cycle improves the next one.

New datasets, immune-response summaries, construct performance, and program feedback can flow back into the ranking engine for future candidate cycles.

Onco-Vira AI
Data Target Construct Readiness Feedback Update